Bristol-Myers Squibb Co at Goldman Sachs Healthcare Conference Transcript
Okay. Let's get underway. Good morning, everybody. Welcome to the second day of the 44th Annual Goldman Sachs Healthcare Conference. We are very pleased to have Bristol-Myers join us. Today from the team an opportunity to really focus in on some of the key business segments, we have Lynelle Hoch, Senior Vice President, Global Cell Therapy franchise live in in-person, you were impressive on Zoom at ASCO; and Roland Chen, who is an SVP in the cardiovascular development, also a very strategic pillar in terms of the portfolio for Bristol.
So what I'd like to do is make these conversations some connectivity that you're not just mouthpieces for Tim and Nina, but we know a little bit about who you are, where you came from. So a quick snap so on your professional journey that brings to bear so that we know how you think about stuff to communicate what's been in your dark and mysterious past? Lynelle you first.
okay. My dark and mysterious past. So Lynelle Hoch, I've been at
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |